|Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the American Diabetes Association and the American College of Cardiology Foundation|
JD Brunzell, M Davidson, CD Furberg, RB Goldberg, BV Howard, ...
Journal of the American college of Cardiology 51 (15), 1512-1524, 2008
|Fixed-dose combinations improve medication compliance: a meta-analysis|
S Bangalore, G Kamalakkannan, S Parkar, FH Messerli
The American journal of medicine 120 (8), 713-719, 2007
|Short-and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials|
S Bangalore, S Kumar, M Fusaro, N Amoroso, MJ Attubato, F Feit, ...
Circulation 125 (23), 2873-2891, 2012
|Obesity paradox in patients with hypertension and coronary artery disease|
S Uretsky, FH Messerli, S Bangalore, A Champion, RM Cooper-DeHoff, ...
The American journal of medicine 120 (10), 863-870, 2007
|Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomizedá…|
S Bangalore, S Kumar, I Lobach, FH Messerli
Circulation 123 (24), 2799-2810, 2011
|β-Blocker use and clinical outcomes in stable outpatients with and without coronary artery disease|
S Bangalore, G Steg, P Deedwania, K Crowley, KA Eagle, S Goto, ...
Jama 308 (13), 1340-1349, 2012
|Atrial fibrillation and obesity—results of a meta-analysis|
N Wanahita, FH Messerli, S Bangalore, AS Gami, VK Somers, ...
American heart journal 155 (2), 310-315, 2008
|Perioperative β blockers in patients having non-cardiac surgery: a meta-analysis|
S Bangalore, J Wetterslev, S Pranesh, S Sawhney, C Gluud, FH Messerli
The Lancet 372 (9654), 1962-1976, 2008
|Relation of beta-blocker–induced heart rate lowering and cardioprotection in hypertension|
S Bangalore, S Sawhney, FH Messerli
Journal of the American College of Cardiology 52 (18), 1482-1489, 2008
|J-curve revisited: an analysis of blood pressure and cardiovascular events in the Treating to New Targets (TNT) Trial|
S Bangalore, FH Messerli, CC Wun, AL Zuckerman, D DeMicco, JB Kostis, ...
European heart journal 31 (23), 2897-2908, 2010
|Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324 168 participants from randomised trials|
S Bangalore, S Kumar, SE Kjeldsen, H Makani, E Grossman, J Wetterslev, ...
The lancet oncology 12 (1), 65-82, 2011
|A meta-analysis of 94,492 patients with hypertension treated with beta blockers to determine the risk of new-onset diabetes mellitus|
S Bangalore, S Parkar, E Grossman, FH Messerli
The American journal of cardiology 100 (8), 1254-1262, 2007
|Cardiovascular protection using beta-blockers: a critical review of the evidence|
S Bangalore, FH Messerli, JB Kostis, CJ Pepine
Journal of the American College of Cardiology 50 (7), 563-572, 2007
|Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis|
S Bangalore, B Toklu, N Amoroso, M Fusaro, S Kumar, EL Hannan, ...
Bmj 347, f6625, 2013
|What is the optimal blood pressure in patients after acute coronary syndromes? Relationship of blood pressure and cardiovascular events in the PRavastatin OR atorVastatiná…|
S Bangalore, J Qin, S Sloan, SA Murphy, CP Cannon, ...
Circulation 122 (21), 2142-2151, 2010
|Diabetes and hypertension: a position statement by the American Diabetes Association|
IH De Boer, S Bangalore, A Benetos, AM Davis, ED Michos, P Muntner, ...
Diabetes Care 40 (9), 1273-1284, 2017
|Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22 844 patient years of follow-up fromá…|
S Bangalore, S Kumar, M Fusaro, N Amoroso, AJ Kirtane, RA Byrne, ...
Bmj 345, e5170, 2012
|Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: a systematic review and meta-analysis of randomized clinical trials|
S Pursnani, F Korley, R Gopaul, P Kanade, N Chandra, RE Shaw, ...
Circulation: Cardiovascular Interventions 5 (4), 476-490, 2012
|Antihypertensive efficacy of hydrochlorothiazide as evaluated by ambulatory blood pressure monitoring: a meta-analysis of randomized trials|
FH Messerli, H Makani, A Benjo, J Romero, C Alviar, S Bangalore
Journal of the American College of Cardiology 57 (5), 590-600, 2011
|Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials|
H Makani, S Bangalore, KA Desouza, A Shah, FH Messerli
BMJ: British Medical Journal 346, 2013